• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

曲古霉素与枸橼酸铋胶体联合应用对幽门螺杆菌的体外抗菌活性

Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.

作者信息

Vogt K, Rodloff A C, Hahn H

机构信息

Institut für Medizinische Mikrobiologie, Freie Universität Berlin.

出版信息

Infection. 1991 May-Jun;19(3):138-9. doi: 10.1007/BF01643232.

DOI:10.1007/BF01643232
PMID:1832417
Abstract

The combined activities of trospectomycin, a spectinomycin analogue, and colloidal bismuth subcitrate against Helicobacter pylori were investigated, the agar dilution method being employed. Forty-seven strains of H. pylori were examined. An additive effect was observed in 89%, and a synergistic interaction in 11% of the isolates. There was no antagonism observed. The MIC50 of trospectomycin against H. pylori was 2 mg/l; the MIC ranged from 0.5 to 4 mg/l.

摘要

研究了大观霉素类似物曲古霉素与枸橼酸铋胶体联合对幽门螺杆菌的活性,采用琼脂稀释法。检测了47株幽门螺杆菌。在89%的分离株中观察到相加作用,11%的分离株中观察到协同相互作用。未观察到拮抗作用。曲古霉素对幽门螺杆菌的MIC50为2mg/L;MIC范围为0.5至4mg/L。

相似文献

1
Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.曲古霉素与枸橼酸铋胶体联合应用对幽门螺杆菌的体外抗菌活性
Infection. 1991 May-Jun;19(3):138-9. doi: 10.1007/BF01643232.
2
Synergism between clindamycin and colloidal bismuth subcitrate against Helicobacter (Campylobacter) pylori in vitro.
Zentralbl Bakteriol. 1990 Nov;274(2):246-9. doi: 10.1016/s0934-8840(11)80107-6.
3
Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate.奥美拉唑和枸橼酸铋钾对甲硝唑抗幽门螺杆菌作用的增效作用。
Int J Antimicrob Agents. 2000 Apr;14(3):231-4. doi: 10.1016/s0924-8579(00)00133-3.
4
In vitro susceptibility of Helicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A).幽门螺杆菌对曲古霉素、匹利霉素(U - 57930E)、米林卡霉素(U - 24729A)和N - 去甲基克林霉素(U - 26767A)的体外敏感性。
Eur J Clin Microbiol Infect Dis. 1993 Jul;12(7):560-2. doi: 10.1007/BF01970966.
5
Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy.硝酸铋和枸橼酸铋胶体的溶解度、吸收及抗幽门螺杆菌活性:体外数据无法预测体内疗效。
Helicobacter. 2000 Sep;5(3):176-82. doi: 10.1046/j.1523-5378.2000.00028.x.
6
Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.酸性环境对幽门螺杆菌对曲古霉素及其他抗菌药物敏感性的影响。
Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):353-5. doi: 10.1007/BF02116532.
7
Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.枸橼酸铋胶体可阻止质子进入幽门螺杆菌,并提高依赖生长的抗生素的疗效。
Aliment Pharmacol Ther. 2015 Oct;42(7):922-33. doi: 10.1111/apt.13346. Epub 2015 Aug 4.
8
[In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].幽门螺杆菌菌株的体外抗菌药敏性:对克拉霉素耐药菌株的分离
Rev Med Chil. 2001 Jun;129(6):643-6.
9
Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.阿莫西林、甲硝唑、水杨酸铋和六种氨基糖苷类药物对幽门螺杆菌的活性。
J Chemother. 1996 Feb;8(1):52-4. doi: 10.1179/joc.1996.8.1.52.
10
The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
Zentralbl Bakteriol. 1989 Sep;271(3):304-10. doi: 10.1016/s0934-8840(89)80028-3.

引用本文的文献

1
In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.奥美拉唑联合多种抗菌药物对幽门螺杆菌临床分离株的体外活性
Eur J Clin Microbiol Infect Dis. 1996 Dec;15(12):937-40. doi: 10.1007/BF01690512.
2
In vitro susceptibility of Helicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A).幽门螺杆菌对曲古霉素、匹利霉素(U - 57930E)、米林卡霉素(U - 24729A)和N - 去甲基克林霉素(U - 26767A)的体外敏感性。
Eur J Clin Microbiol Infect Dis. 1993 Jul;12(7):560-2. doi: 10.1007/BF01970966.
3

本文引用的文献

1
The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.抗生素和抗溃疡药物对幽门弯曲菌的最低抑菌浓度和杀菌浓度。
J Antimicrob Chemother. 1986 Mar;17(3):309-14. doi: 10.1093/jac/17.3.309.
2
[Electron microscopic findings during treatment of Campylobacter pylori-positive gastritis with bismuth salts].[铋盐治疗幽门螺杆菌阳性胃炎过程中的电子显微镜检查结果]
Z Gastroenterol. 1987 Sep;25 Suppl 4:41-3.
3
Campylobacter pyloridis, gastritis, and peptic ulceration.幽门弯曲菌、胃炎与消化性溃疡
Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.
酸性环境对幽门螺杆菌对曲古霉素及其他抗菌药物敏感性的影响。
Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):353-5. doi: 10.1007/BF02116532.
J Clin Pathol. 1986 Apr;39(4):353-65. doi: 10.1136/jcp.39.4.353.
4
Cytopathic effects of Campylobacter pylori urease.幽门螺杆菌脲酶的细胞病变效应。
J Clin Pathol. 1988 May;41(5):597. doi: 10.1136/jcp.41.5.597-a.
5
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.幽门螺杆菌相关的慢性活动性胃窦炎。关于其患病率以及抗菌和抗溃疡治疗效果的前瞻性研究。
Gastroenterology. 1988 Jan;94(1):33-40.
6
Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.通过联合使用枸橼酸铋胶体预防幽门螺杆菌对硝基咪唑的耐药性:临床和体外研究
J Clin Pathol. 1988 Feb;41(2):207-10. doi: 10.1136/jcp.41.2.207.
7
Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species.曲古霉素对脆弱拟杆菌及其他拟杆菌属菌种的活性。
Antimicrob Agents Chemother. 1988 Apr;32(4):584-6. doi: 10.1128/AAC.32.4.584.
8
In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.新型壮观霉素类似物曲氟沙星(U-63366F)的体外抗菌活性
Antimicrob Agents Chemother. 1988 Feb;32(2):216-23. doi: 10.1128/AAC.32.2.216.
9
Campylobacter pylori--therapy review.幽门螺杆菌——治疗综述
Scand J Gastroenterol Suppl. 1989;160:35-8. doi: 10.3109/00365528909091733.
10
Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests.曲帕霉素(U-63366F)的抗菌活性及纸片扩散法药敏试验的初步评估
Antimicrob Agents Chemother. 1989 Apr;33(4):569-72. doi: 10.1128/AAC.33.4.569.